Simplex Trading
BTAI icon

Simplex Trading’s BioXcel Therapeutics BTAI Stock Holding History

Simplex Trading’s Portfolio BTAI Stock Details BTAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,900
Closed -$4K – 8577
2024
Q4 		$4K Buy
1,900
+1,581
+496% +$13.2K ﹤0.01% 7707
2024
Q3 		$3K Sell
319
-175
-35% -$2.35K ﹤0.01% 7810
2024
Q2 		$10K Buy
494
+25
+5% +$837 ﹤0.01% 7402
2024
Q1 		$21K Sell
469
-4,462
-90% -$213K ﹤0.01% 7041
2023
Q4 		$232K Buy
4,931
+3,375
+217% +$188K ﹤0.01% 4513
2023
Q3 		$62K Sell
1,556
-10,019
-87% -$1.01M ﹤0.01% 5591
2023
Q2 		$1.23M Buy
11,575
+10,112
+691% +$3.37M ﹤0.01% 2398
2023
Q1 		$436K Buy
1,463
+1,057
+260% +$451K ﹤0.01% 3418
2022
Q4 		$139K Sell
406
-819
-67% -$198K ﹤0.01% 4674
2022
Q3 		$231K Buy
1,225
+656
+115% +$152K ﹤0.01% 4419
2022
Q2 		$120K Buy
569
+481
+547% +$101K ﹤0.01% 5308
2022
Q1 		$29K Sell
88
-1,781
-95% -$516K ﹤0.01% 7799
2021
Q4 		$607K Buy
1,869
+1,600
+595% +$687K ﹤0.01% 3540
2021
Q3 		$123K Hold
269
– – ﹤0.01% 6321
2021
Q2 		$124K Buy
269
+267
+13,350% +$146K ﹤0.01% 6412
2021
Q1 		$151K Buy
+2
New +$1.61K ﹤0.01% 5171
2020
Q3 		– Sell
-22
Closed -$1.86M – 7799
2020
Q2 		$1.86M Buy
22
+21
+2,100% +$13.7K ﹤0.01% 1571
2020
Q1 		$17K Buy
+1
New +$359 ﹤0.01% 6077

Other funds holding BTAI

M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Simplex Trading's BTAI Position: Q4 2024 in Review

Simplex Trading sold out of BioXcel Therapeutics (BTAI) in Q4 2024, closing a stake of 195 shares — an estimated $1.63K sold.

Simplex Trading first reported a position in BTAI in Q1 2020 and held it in 14 quarters. The position peaked at $1.66M in Q2 2020. 49 funds tracked by Wall St. Rank hold BTAI as of Q4 2024.

  • Simplex Trading reported no remaining BioXcel Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Simplex Trading sold 195 BioXcel Therapeutics shares in Q4 2024, an estimated $1.63K.
  • Simplex Trading first reported a position in BioXcel Therapeutics in Q1 2020 and held it in 14 quarters.
  • Simplex Trading's BioXcel Therapeutics position peaked at $1.66M in Q2 2020.
  • 49 funds tracked by Wall St. Rank held BioXcel Therapeutics as of Q4 2024.

Based on Simplex Trading's 13F filing for Q4 2024, filed 11 Feb 2025.